Dow AgroSciences Receives Regulatory Approval for Plant-Made Vaccine

February 2, 2006
Patricia Van Arnum

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

ePT--the Electronic Newsletter of Pharmaceutical Technology

Dow AgroSciences Receives Regulatory Approval for Plant-Made Vaccine

Dow AgroSciences LLC (Indianapolis, IN, www.dowagro.com), a wholly owned subsidiary of The Dow Chemical Company (Midland, MI, www.dow.com), has received regulatory approval for a plant-cell-culture-derived vaccine from the US Department of Agriculture Center for Veterinary Biologics.

The vaccine is produced from the “DowAgroSciences Concert Plant-Cell-Produced System” that uses plant cells instead of whole plants in a biocontained environment to produce vaccines. With the approval, Dow AgroSciences says that it can focus its efforts on developing vaccines for animal health and that using this technology for human vaccines is a possibility.